Financial results: ECS Botanics; Epsilon Healthcare by Martin Lane October 7, 2025February 21, 2026 ECS Botanics’ B2C division now accounts for more than half of the firm’s revenue in a […]
News in brief: Wragg joins ANTG; Bioxyne launches legal claim; Epsilon appoints Kaplon by Martin Lane August 28, 2025February 21, 2026
Old wounds reopen as Epsilon demands repayment of funds from former chairman by Steve Jones August 7, 2025August 7, 2025
Epsilon reduces debt through sale and leaseback of Southport facility by Steve Jones July 29, 2025July 29, 2025
Directors injected $700K and put up personal property to save Epsilon from collapse, CEO reveals by Steve Jones June 30, 2025June 30, 2025
Exiting administration ‘no easy task’, says Epsilon CEO as firm begins ‘new chapter’ by Adam Sheldon May 28, 2025May 28, 2025
News in brief: Carmen Doran to chair NZMCC; ECS Botanics tips record harvest; Elixinol and Epsilon raise capital by Martin Lane and Steve Jones May 21, 2025May 21, 2025
Epsilon takes legal action against former chairman amid payment allegations by Steve Jones May 21, 2025May 22, 2025
News in brief: LCWA; Epsilon; Vitura Health; NZ hemp rules by Martin Lane February 26, 2025February 26, 2025
Epsilon sets out ‘roadmap’ but issues remain as firm seeks ASX return by Steve Jones December 17, 2024December 20, 2024
